Press Releases
FBL pioneers the development of its patented enzymatic route of synthesis for Molunpiravir an investigational ” orally active” therapeutic alternative for COVID 19
“With the more we understand of COVID 19 the less we fear it and it is through this understanding that we can potentially create impressive therapeutic developments” says Mr. Prashant Nagre, CEO, FBL as he expounds further on the...
Press Releases
Dr Reddy’s Lab gets emergency use authorisation for Sputnik V in India
Dr. Reddy’s Laboratories Ltd. announced that it has received the permission from the Drug Controller General of India(DCGI)to import the Sputnik vaccine into India for restricted use in emergency situationsas per the provisions of the New Drug and Clincial...
Drug Research
Sanofi to invest in a leading-edge production site in Singapore; continues to strengthen its vaccines manufacturing capacities
Sanofi announced a €400 million investment over five years to create a unique vaccine production center in Singapore, pushing the boundaries of operations through cutting edge manufacturing and digital technologies. In partnership with the Singapore Economic Development Board (EDB),...
Drug Research
Airway Therapeutics Announces FDA Acceptance of IND for AT-100’s Second Indication in Severe COVID-19 Patients
Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases, announced the U.S. FDA has accepted its Investigational New Drug (IND) application...
Clinical Trials
Catalent Biologics Completes Madison Facility Expansion to Double Clinical and Commercial Drug Substance Capacity
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it has completed the expansion of two new suites at its biologics drug...
Packaging & Labelling
CEVA Logistics launches FORPATIENTS healthcare logistics sub-brand, new temperature-sensitive solution
In an expansion of its support for global healthcare and pharmaceutical customers, CEVA Logistics announced today, on World Health Day, a new sub-brand to support better patient outcomes through the company’s broad range of healthcare logistics services. CEVA FORPATIENTS...
Clinical Trials
Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients
Eli Lilly and Company and Incyte announced results of COV-BARRIER, a Phase 3 study evaluating baricitinib 4 mg once daily plus standard of care (SoC) versus placebo plus SoC. The trial did not meet statistical significance on the primary...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read